Less than half of England has access to Mounjaro on the NHS months after roll-out
Over 200,000 patients may be eligible for treatment in the first three years, but some commissioners are already considering tighter prescribing criteria or rationing Figures confirm the fear that the roll out is not fit for purpose, says expert Less than half of England has access to tirzepatide (Mounjaro) through ...